Contract VA26116F1243
Seqirus USA Inc · Department Of Veterans Affairs · March 30, 2016
Seqirus USA Inc was awarded a federal contract by Department Of Veterans Affairs on March 30, 2016 for $102,000 of work in pharmaceutical preparation manufacturing. Performance is in King Of Prussia, PA. This is a task or delivery order issued under parent IDIQ VA797P16C0026. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 8, 2020.
Contract details
- PIID
- VA26116F1243
- Parent IDIQ
- VA797P16C0026
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- King Of Prussia, PA
- First action
- March 30, 2016
- Latest action
- April 8, 2020
Description
INFLUENZA VACCINE
Modification timeline
-
April 8, 2020Mod P00001$-855
-
July 19, 2017Mod P00002IGF::OT::IGF ASEPTIC JANITORIAL SERVICES FOR VA SONORA, CA CBOC.$8.9K
-
October 1, 2016Mod P00001IGF::OT::IGF ASEPTIC JANITORIAL SERVICES FOR VA SONORA, CA CBOC.$26.6K
-
March 31, 2016Base awardIGF::OT::IGF ASEPTIC JANITORIAL SERVICES FOR VA SONORA, CA CBOC.$53.2K
-
March 30, 2016Base award$14.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract VA26116F1243?
Contract VA26116F1243 is a federal contract awarded to Seqirus USA Inc by Department Of Veterans Affairs on March 30, 2016 for $102,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract VA26116F1243?
Seqirus USA Inc won contract VA26116F1243 from Department Of Veterans Affairs.
How much is contract VA26116F1243 worth?
Contract VA26116F1243 has obligated $102,000 to date.